BE vs. AZN
BE (Bloom Energy Corporation) and AZN (AstraZeneca PLC) are both stocks. BE operates in Electrical Equipment & Parts (Industrials), while AZN operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, BE returned 58.49%/yr vs 12.08%/yr for AZN. At a 0.14 correlation, their price movements are largely independent.
Performance
BE vs. AZN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BE achieves a 191.83% return, which is significantly higher than AZN's 0.81% return.
BE
- 1D
- -3.81%
- 1M
- -2.86%
- YTD
- 191.83%
- 6M
- 126.83%
- 1Y
- 1,064.23%
- 3Y*
- 155.85%
- 5Y*
- 58.49%
- 10Y*
- —
AZN
- 1D
- -2.37%
- 1M
- -0.71%
- YTD
- 0.81%
- 6M
- 1.53%
- 1Y
- 28.04%
- 3Y*
- 9.54%
- 5Y*
- 12.08%
- 10Y*
- 15.85%
BE vs. AZN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BE Bloom Energy Corporation | 191.83% | 291.22% | 50.07% | -22.59% | -12.81% | -23.48% | 283.67% | -25.15% | -60.08% |
AZN AstraZeneca PLC | 0.81% | 43.30% | -0.62% | 1.44% | 19.14% | 19.66% | 3.12% | 35.68% | 2.62% |
Correlation
The correlation between BE and AZN is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Jul 26, 2018 | 0.14 |
The correlation between BE and AZN shifts across timeframes, from 0.04 (1 year) to 0.16 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
BE:
$81.07B
AZN:
$283.40B
BE:
$0.02
AZN:
$6.66
BE:
11.04K
AZN:
27.27
BE:
27.20
AZN:
4.69
BE:
87.98
AZN:
5.99
BE:
$2.45B
AZN:
$60.44B
BE:
$761.91M
AZN:
$49.37B
BE:
$88.83M
AZN:
$20.47B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BE vs. AZN — Risk / Return Rank
BE
AZN
BE vs. AZN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bloom Energy Corporation (BE) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BE | AZN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +8.95 | ||
| Sortino ratioReturn per unit of downside risk | +3.10 | ||
| Omega ratioGain probability vs. loss probability | 1.62 | 1.21 | +0.41 |
| Calmar ratioReturn relative to maximum drawdown | 23.42 | 1.83 | +21.58 |
| Martin ratioReturn relative to average drawdown | 73.60 | 4.90 | +68.70 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BE | AZN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 10.06 | 1.11 | +8.95 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.69 | 0.51 | +0.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.64 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.36 | 0.49 | -0.13 |
Drawdowns
BE vs. AZN - Drawdown Comparison
The maximum BE drawdown since its inception was -92.54%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for BE and AZN.
Loading charts...
Drawdown Indicators
| BE | AZN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.54% | -48.94% | -43.60% |
Max Drawdown (1Y)Largest decline over 1 year | -45.94% | -15.43% | -30.51% |
Max Drawdown (3Y)Largest decline over 3 years | -53.42% | -27.87% | -25.55% |
Max Drawdown (5Y)Largest decline over 5 years | -75.87% | -27.87% | -48.00% |
Max Drawdown (10Y)Largest decline over 10 years | — | -27.87% | — |
Current DrawdownCurrent decline from peak | -17.64% | -12.90% | -4.74% |
Average DrawdownAverage peak-to-trough decline | -52.00% | -11.37% | -40.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.59% | 5.75% | +8.84% |
Volatility
BE vs. AZN - Volatility Comparison
Bloom Energy Corporation (BE) has a higher volatility of 26.19% compared to AstraZeneca PLC (AZN) at 7.42%. This indicates that BE's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BE | AZN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.19% | 7.42% | +18.77% |
Volatility (6M)Calculated over the trailing 6-month period | 75.40% | 17.47% | +57.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 107.17% | 25.55% | +81.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.83% | 24.02% | +61.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 94.94% | 24.94% | +70.00% |
Dividends
BE vs. AZN - Dividend Comparison
BE has not paid dividends to shareholders, while AZN's dividend yield for the trailing twelve months is around 2.93%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 2.93% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
BE Bloom Energy Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
BE vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between Bloom Energy Corporation and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BE vs. AZN - Profitability Comparison
BE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bloom Energy Corporation reported a gross profit of 225.54M and revenue of 751.05M. Therefore, the gross margin over that period was 30.0%.
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.
BE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bloom Energy Corporation reported an operating income of 72.19M and revenue of 751.05M, resulting in an operating margin of 9.6%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.
BE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bloom Energy Corporation reported a net income of 70.65M and revenue of 751.05M, resulting in a net margin of 9.4%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.
Frequently Asked Questions
BE and AZN have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BE has higher volatility (26.19%) compared to AZN (7.42%). In terms of maximum drawdown, BE dropped -92.54% vs AZN's -48.94%.
BE currently has the higher Sharpe Ratio (10.06 vs 1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BE and AZN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer